Hana Must SPAC 2 (208370) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Hana Must SPAC 2 for the company's overall valuation and market capitalisation.
Hana Must SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency. Explore Hana Must SPAC 2 (208370) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DynaCERT Inc.
TO:DYA
|
2.389x |
|
LEMON Co. Ltd
KQ:294140
|
-0.269x |
|
Inbest Prime VI Inmuebles Socimi SA
MC:YINB6
|
0.017x |
|
Eskay Mining Corp
V:ESK
|
-0.087x |
|
Goldbank Mining Corp
V:GLB
|
0.005x |
|
Inhwa Precision Co. Ltd
KQ:101930
|
0.012x |
|
Nirvana Daii Public Company Limited
BK:NVD
|
0.045x |
|
Indiabulls Enterprises Limited
NSE:IEL
|
N/A |
Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)
The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. View latest Hana Must SPAC 2 stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩63.80 Billion ≈ $43.24 Million |
₩4.50 Billion ≈ $3.05 Million |
0.071x | +22.09% |
| 2023-12-31 | ₩60.10 Billion ≈ $40.73 Million |
₩3.47 Billion ≈ $2.35 Million |
0.058x | +3640.27% |
| 2022-12-31 | ₩32.89 Billion ≈ $22.29 Million |
₩50.81 Million ≈ $34.43K |
0.002x | -98.52% |
| 2021-12-31 | ₩28.06 Billion ≈ $19.02 Million |
₩2.93 Billion ≈ $1.98 Million |
0.104x | -38.53% |
| 2020-12-31 | ₩24.89 Billion ≈ $16.87 Million |
₩4.23 Billion ≈ $2.86 Million |
0.170x | +11.18% |
| 2019-12-31 | ₩24.14 Billion ≈ $16.36 Million |
₩3.69 Billion ≈ $2.50 Million |
0.153x | +132.33% |
| 2018-12-31 | ₩14.60 Billion ≈ $9.90 Million |
₩-6.90 Billion ≈ $-4.67 Million |
-0.472x | -205.32% |
| 2017-12-31 | ₩27.81 Billion ≈ $18.85 Million |
₩-4.30 Billion ≈ $-2.92 Million |
-0.155x | +33.13% |
| 2016-12-31 | ₩26.92 Billion ≈ $18.24 Million |
₩-6.23 Billion ≈ $-4.22 Million |
-0.231x | -2788.35% |
| 2015-12-31 | ₩19.09 Billion ≈ $12.94 Million |
₩164.29 Million ≈ $111.33K |
0.009x | -- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more